Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention
Related Experiment Video
Updated: Apr 21, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Renato Budzyn David1, Eduardo Dytz Almeida1, Larissa Vargas Cruz1
1Instituto de Cardiologia, Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.
Insights
Admission blood glucose is a stronger predictor of 30-day mortality in ST-elevation myocardial infarction patients undergoing primary PCI than a diabetes mellitus diagnosis. This highlights the critical role of glycemic control in cardiovascular outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus and admission blood glucose are known risk factors for mortality in ST-elevation myocardial infarction (STEMI) patients.
- The independent and relative contributions of these factors to mortality remain debated.
Purpose of the Study:
- To investigate the influence of diabetes mellitus and admission blood glucose on mortality in STEMI patients undergoing primary percutaneous coronary intervention (PCI).
Main Methods:
- A prospective cohort study included 740 STEMI patients undergoing primary PCI.
- Data collected included clinical, angiographic, and laboratory parameters.
- Multivariate analysis adjusted for GRACE score variables, with 30-day follow-up.
Main Results:
- Diabetes mellitus prevalence was 18%.
- Univariate analysis showed both diabetes and admission glucose predicted 30-day mortality.
- Multivariate analysis revealed admission blood glucose as an independent predictor (RR 1.05, CI 1.02-1.09, p≤0.01), while diabetes mellitus did not (RR 2.41, CI 0.76-7.59, p=0.13).
Conclusions:
- Admission blood glucose is a more accurate and robust predictor of 30-day mortality in STEMI patients post-primary PCI than a prior diabetes diagnosis.
- This finding underscores the significant role of inflammation and glycemic status in patient outcomes.
Background:
Diabetes mellitus and admission blood glucose are important risk factors for mortality in ST segment elevation myocardial infarction patients, but their relative and individual role remains on debate.
Objective:
To analyze the influence of diabetes mellitus and admission blood glucose on the mortality of ST segment elevation myocardial infarction patients submitted to primary coronary percutaneous intervention.
Methods:
Prospective cohort study including every ST segment elevation myocardial infarction patient submitted to primary coronary percutaneous intervention in a tertiary cardiology center from December 2010 to May 2012. We collected clinical, angiographic and laboratory data during hospital stay, and performed a clinical follow-up 30 days after the ST segment elevation myocardial infarction. We adjusted the multivariate analysis of the studied risk factors using the variables from the GRACE score.
Results:
Among the 740 patients included, reported diabetes mellitus prevalence was 18%. On the univariate analysis, both diabetes mellitus and admission blood glucose were predictors of death in 30 days. However, after adjusting for potential confounders in the multivariate analysis, the diabetes mellitus relative risk was no longer significant (relative risk: 2.41, 95% confidence interval: 0.76 - 7.59; p-value: 0.13), whereas admission blood glucose remained and independent predictor of death in 30 days (relative risk: 1.05, 95% confidence interval: 1.02 - 1.09; p-value ≤ 0.01).
Conclusion:
In ST segment elevation myocardial infarction patients submitted to primary coronary percutaneous intervention, the admission blood glucose was a more accurate and robust independent predictor of death than the previous diagnosis of diabetes. This reinforces the important role of inflammation on the outcomes of this group of patients.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Coronary Artery Disease I: Introduction